Last 12 months
Inside the activity.
9 purchase rows · 3 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 9 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 02, 2026 Filed Oct 9, 2026 20:22 UTC |
Elfrink WillemDirector
|
GrantStock Option (right to buy) · Derivative | 93,750 | $0.00 Strike: $0.44 | $0.00 |
DisclosureSEC source: 0001213900-26-108491 · ownership.xml · derivative · entry 2 Elfrink Willem · CIK 0001893194 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 93,750 Underlying: Common Stock · 93,750 shares Expires 2036-10-02 F3 · derivative.exercise_date: The stock option was granted on October 2, 2026 under the Plan. The option vests as to one-half (1/2) of the underlying shares on the grant date, and as to the remaining one-half (1/2) on January 1, 2027, subject to the Reporting Person's continued service as a non-employee director through the applicable vesting date, with full acceleration of any then-unvested shares immediately prior to a Change in Control (as defined in the Plan). Read SEC document |
| October 02, 2026 Filed Oct 9, 2026 20:22 UTC |
Elfrink WillemDirector
|
GrantRestricted Stock Units · Derivative | 93,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-26-108491 · ownership.xml · derivative · entry 1 Elfrink Willem · CIK 0001893194 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 93,750 Underlying: Common Stock · 93,750 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock upon vesting. F2 · derivative.exercise_date: The RSUs were granted on October 2, 2026 under the Issuer's 2022 Equity Incentive Plan, as amended (the "Plan"), as an annual RSU award to non-employee directors. One hundred percent (100%) of the RSUs will vest on the earlier of October 2, 2027 or the date of the Issuer's next annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service as a non-employee director through the vesting date. Vested RSUs will be settled in shares of common stock. RSUs do not expire. F2 · derivative.expiration_date: The RSUs were granted on October 2, 2026 under the Issuer's 2022 Equity Incentive Plan, as amended (the "Plan"), as an annual RSU award to non-employee directors. One hundred percent (100%) of the RSUs will vest on the earlier of October 2, 2027 or the date of the Issuer's next annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service as a non-employee director through the vesting date. Vested RSUs will be settled in shares of common stock. RSUs do not expire. Read SEC document |
| October 02, 2026 Filed Oct 9, 2026 20:22 UTC |
Ferrari RichardDirector
|
GrantStock Option (Right to Buy) · Derivative | 125,000 | $0.00 Strike: $0.44 | $0.00 |
DisclosureSEC source: 0001213900-26-108490 · ownership.xml · derivative · entry 3 Ferrari Richard · CIK 0001034413 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires 2036-10-02 F4 · derivative.exercise_date: Represents a nonqualified stock option granted to the Reporting Person on October 2, 2026 under the Plan in connection with the Reporting Person's additional responsibilities as Chair of the Board. One-twelfth of the shares subject to the option vest on each monthly anniversary of July 1, 2026, such that 3/12ths of the shares subject to the option were vested on the grant date and the option will be fully vested on July 1, 2027, subject to the Reporting Person's continued service as a director through each vesting date. Read SEC document |
| October 02, 2026 Filed Oct 9, 2026 20:22 UTC |
Ferrari RichardDirector
|
GrantRestricted Stock Units · Derivative | 90,625 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-26-108490 · ownership.xml · derivative · entry 2 Ferrari Richard · CIK 0001034413 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,625 Underlying: Common Stock · 90,625 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock upon vesting. F3 · derivative.exercise_date: Represents a special RSU award granted to the Reporting Person on October 2, 2026 under the Plan in connection with the suspension of cash retainers for the period of July 1, 2026 through December 31, 2026. One-half of the RSUs vested on the grant date, and the remaining RSUs will vest on January 1, 2027, subject to the Reporting Person's continued service as a director through the vesting date. All unvested RSUs will vest in full immediately prior to a Change in Control (as defined in the Plan), subject to the Reporting Person's continued service as a director through such date. F3 · derivative.expiration_date: Represents a special RSU award granted to the Reporting Person on October 2, 2026 under the Plan in connection with the suspension of cash retainers for the period of July 1, 2026 through December 31, 2026. One-half of the RSUs vested on the grant date, and the remaining RSUs will vest on January 1, 2027, subject to the Reporting Person's continued service as a director through the vesting date. All unvested RSUs will vest in full immediately prior to a Change in Control (as defined in the Plan), subject to the Reporting Person's continued service as a director through such date. Read SEC document |
| October 02, 2026 Filed Oct 9, 2026 20:22 UTC |
Ferrari RichardDirector
|
GrantRestricted Stock Units · Derivative | 125,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-26-108490 · ownership.xml · derivative · entry 1 Ferrari Richard · CIK 0001034413 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock upon vesting. F2 · derivative.exercise_date: The RSUs were granted on October 2, 2026 under the Issuer's 2022 Equity Incentive Plan, as amended (the "Plan"), as an annual RSU award to non-employee directors. One hundred percent (100%) of the RSUs will vest on the earlier of October 2, 2027 or the date of the Issuer's next annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service as a non-employee director through the vesting date. Vested RSUs will be settled in shares of common stock. RSUs do not expire. F2 · derivative.expiration_date: The RSUs were granted on October 2, 2026 under the Issuer's 2022 Equity Incentive Plan, as amended (the "Plan"), as an annual RSU award to non-employee directors. One hundred percent (100%) of the RSUs will vest on the earlier of October 2, 2027 or the date of the Issuer's next annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service as a non-employee director through the vesting date. Vested RSUs will be settled in shares of common stock. RSUs do not expire. Read SEC document |
| October 02, 2026 Filed Oct 9, 2026 20:22 UTC |
JAFF MICHAEL RDirector
|
GrantRestricted Stock Units · Derivative | 37,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-26-108489 · ownership.xml · derivative · entry 2 JAFF MICHAEL R · CIK 0001988352 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,500 Underlying: Common Stock · 37,500 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock upon vesting. F3 · derivative.exercise_date: Represents a special RSU award granted to the Reporting Person on October 2, 2026 under the Plan in connection with the suspension of cash retainers for the period of July 1, 2026 through December 31, 2026. One-half of the RSUs vested on the grant date, and the remaining RSUs will vest on January 1, 2027, subject to the Reporting Person's continued service as a director through the vesting date. All unvested RSUs will vest in full immediately prior to a Change in Control (as defined in the Plan), subject to the Reporting Person's continued service as a director through such date. F3 · derivative.expiration_date: Represents a special RSU award granted to the Reporting Person on October 2, 2026 under the Plan in connection with the suspension of cash retainers for the period of July 1, 2026 through December 31, 2026. One-half of the RSUs vested on the grant date, and the remaining RSUs will vest on January 1, 2027, subject to the Reporting Person's continued service as a director through the vesting date. All unvested RSUs will vest in full immediately prior to a Change in Control (as defined in the Plan), subject to the Reporting Person's continued service as a director through such date. Read SEC document |
| October 02, 2026 Filed Oct 9, 2026 20:22 UTC |
JAFF MICHAEL RDirector
|
GrantRestricted Stock Units · Derivative | 93,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-26-108489 · ownership.xml · derivative · entry 1 JAFF MICHAEL R · CIK 0001988352 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 93,750 Underlying: Common Stock · 93,750 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock upon vesting. F2 · derivative.exercise_date: The RSUs were granted on October 2, 2026 under the Issuer's 2022 Equity Incentive Plan, as amended (the "Plan"), as an annual RSU award to non-employee directors. One hundred percent (100%) of the RSUs will vest on the earlier of October 2, 2027 or the date of the Issuer's next annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service as a non-employee director through the vesting date. Vested RSUs will be settled in shares of common stock. RSUs do not expire. F2 · derivative.expiration_date: The RSUs were granted on October 2, 2026 under the Issuer's 2022 Equity Incentive Plan, as amended (the "Plan"), as an annual RSU award to non-employee directors. One hundred percent (100%) of the RSUs will vest on the earlier of October 2, 2027 or the date of the Issuer's next annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service as a non-employee director through the vesting date. Vested RSUs will be settled in shares of common stock. RSUs do not expire. Read SEC document |
| October 02, 2026 Filed Oct 9, 2026 20:21 UTC |
Ortigas-Wedekind MargaDirector
|
GrantStock Option (right to buy) · Derivative | 81,250 | $0.00 Strike: $0.44 | $0.00 |
DisclosureSEC source: 0001213900-26-108488 · ownership.xml · derivative · entry 2 Ortigas-Wedekind Marga · CIK 0001453971 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,250 Underlying: Common Stock · 81,250 shares Expires 2036-10-02 F3 · derivative.exercise_date: The stock option was granted on October 2, 2026 under the Plan. The option vests as to one-half (1/2) of the underlying shares on the grant date, and as to the remaining one-half (1/2) on January 1, 2027, subject to the Reporting Person's continued service as a non-employee director through the applicable vesting date, with full acceleration of any then-unvested shares immediately prior to a Change in Control (as defined in the Plan). Read SEC document |
| October 02, 2026 Filed Oct 9, 2026 20:21 UTC |
Ortigas-Wedekind MargaDirector
|
GrantRestricted Stock Units · Derivative | 93,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-26-108488 · ownership.xml · derivative · entry 1 Ortigas-Wedekind Marga · CIK 0001453971 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 93,750 Underlying: Common Stock · 93,750 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock upon vesting. F2 · derivative.exercise_date: The RSUs were granted on October 2, 2026 under the Issuer's 2022 Equity Incentive Plan, as amended (the "Plan"), as an annual RSU award to non-employee directors. One hundred percent (100%) of the RSUs will vest on the earlier of October 2, 2027 or the date of the Issuer's next annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service as a non-employee director through the vesting date. Vested RSUs will be settled in shares of common stock. RSUs do not expire. F2 · derivative.expiration_date: The RSUs were granted on October 2, 2026 under the Issuer's 2022 Equity Incentive Plan, as amended (the "Plan"), as an annual RSU award to non-employee directors. One hundred percent (100%) of the RSUs will vest on the earlier of October 2, 2027 or the date of the Issuer's next annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service as a non-employee director through the vesting date. Vested RSUs will be settled in shares of common stock. RSUs do not expire. Read SEC document |
| October 02, 2026 Filed Oct 9, 2026 20:21 UTC |
Nelson Kenneth Warwick IIIDirector
|
GrantRestricted Stock Units · Derivative | 31,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-26-108487 · ownership.xml · derivative · entry 2 Nelson Kenneth Warwick III · CIK 0001981293 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,250 Underlying: Common Stock · 31,250 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock upon settlement. F3 · derivative.exercise_date: Represents a special RSU award granted to the Reporting Person on October 2, 2026 under the Plan in connection with the suspension of cash retainers for the period of July 1, 2026 through December 31, 2026. One-half of the RSUs vested on the grant date, and the remaining RSUs will vest on January 1, 2027, subject to the Reporting Person's continued service as a director through the vesting date. All unvested RSUs will vest in full immediately prior to a Change in Control (as defined in the Plan), subject to the Reporting Person's continued service as a director through such date. F3 · derivative.expiration_date: Represents a special RSU award granted to the Reporting Person on October 2, 2026 under the Plan in connection with the suspension of cash retainers for the period of July 1, 2026 through December 31, 2026. One-half of the RSUs vested on the grant date, and the remaining RSUs will vest on January 1, 2027, subject to the Reporting Person's continued service as a director through the vesting date. All unvested RSUs will vest in full immediately prior to a Change in Control (as defined in the Plan), subject to the Reporting Person's continued service as a director through such date. Read SEC document |
| October 02, 2026 Filed Oct 9, 2026 20:21 UTC |
Nelson Kenneth Warwick IIIDirector
|
GrantRestricted Stock Units · Derivative | 93,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-26-108487 · ownership.xml · derivative · entry 1 Nelson Kenneth Warwick III · CIK 0001981293 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 93,750 Underlying: Common Stock · 93,750 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock upon settlement. F2 · derivative.exercise_date: The RSUs were granted on October 2, 2026 under the Issuer's 2022 Equity Incentive Plan, as amended (the "Plan"), as an annual RSU award to non-employee directors. One hundred percent (100%) of the RSUs will vest on the earlier of October 2, 2027 or the date of the Issuer's next annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service as a non-employee director through the vesting date. Vested RSUs will be settled in shares of common stock. RSUs do not expire. F2 · derivative.expiration_date: The RSUs were granted on October 2, 2026 under the Issuer's 2022 Equity Incentive Plan, as amended (the "Plan"), as an annual RSU award to non-employee directors. One hundred percent (100%) of the RSUs will vest on the earlier of October 2, 2027 or the date of the Issuer's next annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service as a non-employee director through the vesting date. Vested RSUs will be settled in shares of common stock. RSUs do not expire. Read SEC document |
| October 02, 2026 Filed Oct 9, 2026 20:21 UTC |
de Urioste GeorgeDirector
|
GrantStock Option (Right to Buy) · Derivative | 93,750 | $0.00 Strike: $0.44 | $0.00 |
DisclosureSEC source: 0001213900-26-108486 · ownership.xml · derivative · entry 2 de Urioste George · CIK 0001270068 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 93,750 Underlying: Common Stock · 93,750 shares Expires 2036-10-02 F3 · derivative.exercise_date: The stock option was granted on October 2, 2026 under the Plan. The option vests as to one-half (1/2) of the underlying shares on the grant date, and as to the remaining one-half (1/2) on January 1, 2027, subject to the Reporting Person's continued service as a non-employee director through the applicable vesting date, with full acceleration of any then-unvested shares immediately prior to a Change in Control (as defined in the Plan). Read SEC document |
| October 02, 2026 Filed Oct 9, 2026 20:21 UTC |
de Urioste GeorgeDirector
|
GrantRestricted Stock Units · Derivative | 93,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-26-108486 · ownership.xml · derivative · entry 1 de Urioste George · CIK 0001270068 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 93,750 Underlying: Common Stock · 93,750 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock upon settlement. F2 · derivative.exercise_date: The RSUs were granted on October 2, 2026 under the Issuer's 2022 Equity Incentive Plan, as amended (the "Plan"), as an annual RSU award to non-employee directors. One hundred percent (100%) of the RSUs will vest on the earlier of October 2, 2027 or the date of the Issuer's next annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service as a non-employee director through the vesting date. Vested RSUs will be settled in shares of common stock. RSUs do not expire. F2 · derivative.expiration_date: The RSUs were granted on October 2, 2026 under the Issuer's 2022 Equity Incentive Plan, as amended (the "Plan"), as an annual RSU award to non-employee directors. One hundred percent (100%) of the RSUs will vest on the earlier of October 2, 2027 or the date of the Issuer's next annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service as a non-employee director through the vesting date. Vested RSUs will be settled in shares of common stock. RSUs do not expire. Read SEC document |
| July 24, 2026 Filed Jul 24, 2026 20:54 UTC | GrantCommon Stock | 167,760 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-26-081455 · ownership.xml · nonDerivative · entry 1 Cruickshank Tim · CIK 0002038418 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 239,990 F1 · shares: Represents Restricted Stock Units ("RSUs") granted on July 24, 2026 under the HeartBeam, Inc. 2022 Equity Incentive Plan. The RSUs vested in full on the grant date and relate to the settlement of the 2025 Bonus Program, whereby Executives received shares-in-lieu-of-cash. Read SEC document |
|
| July 24, 2026 Filed Jul 24, 2026 20:55 UTC |
Persen Kenneth HarryChief Technology Officer
|
GrantCommon Stock | 105,740 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-26-081458 · ownership.xml · nonDerivative · entry 1 Persen Kenneth Harry · CIK 0001942350 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 448,290 F1 · shares: Represents Restricted Stock Units ("RSUs") granted on July 24, 2026 under the HeartBeam, Inc. 2022 Equity Incentive Plan. The RSUs vested in full on the grant date and relate to the settlement of the 2025 Bonus Program, whereby Executives received shares-in-lieu-of-cash. Read SEC document |
| July 24, 2026 Filed Jul 24, 2026 20:53 UTC |
Vajdic BranislavDirector · President
|
GrantCommon Stock | 260,870 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-26-081450 · ownership.xml · nonDerivative · entry 2 Vajdic Branislav · CIK 0001422425 · Director · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,970,784 F2 · shares: Represents Restricted Stock Units ("RSUs") granted on July 24, 2026 under the HeartBeam, Inc. 2022 Equity Incentive Plan. The RSUs vested in full on the grant date and relate to the settlement of the 2025 Bonus Program, whereby Executives received shares-in-lieu-of-cash. Read SEC document |
| June 15, 2026 Filed Jul 24, 2026 20:53 UTC |
Vajdic BranislavDirector · President
|
GrantCommon Stock | 2,800,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-26-081450 · ownership.xml · nonDerivative · entry 1 Vajdic Branislav · CIK 0001422425 · Director · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,709,914 F1 · shares: Represents the grant of 2,800,000 performance-based restricted stock units ("PRSUs") under the HeartBeam, Inc. 2022 Equity Incentive Plan on June 15, 2026. The PRSUs are subject to performance-based milestones and service-based vesting conditions over a three-year period. Each PRSU represents a contingent right to receive one share of Common Stock upon vesting. Read SEC document |
| April 16, 2026 Filed Apr 17, 2026 00:46 UTC |
STROME MARK EDirector
|
PurchaseCommon Stock | 750,000 | $0.80 | $600,000.00 |
DisclosureSEC source: 0001213900-26-044832 · ownership.xml · nonDerivative · entry 1 STROME MARK E · CIK 0000919484 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 3,650,000 F1 · shares: These shares were purchased in connection with the Registrant's underwritten public offering of 12,500,000 shares of common stock. Titan Partners, a division of American Capital Partners, acted as the sole bookrunner for the offering, which priced on April 14, 2026, and closed on April 16, 2026. F2 · ownership.nature: The reported securities are held directly by Strome Mezzanine Fund II, LP, Mark E. Strome Living Trust and Strome Dynasty, LLC. Mr. Strome has the authority to vote and dispose of the reported securities held by each of these entities. Mr. Strome disclaims beneficial ownership of the reported securities, except to the extent of his pecuniary interest therein. This report shall not be deemed an admission that Mr. Strome is a beneficial owner of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Read SEC document |
| April 16, 2026 Filed Apr 17, 2026 00:47 UTC |
Ferrari RichardDirector
|
PurchaseCommon Stock | 62,500 | $0.80 | $50,000.00 |
DisclosureSEC source: 0001213900-26-044835 · ownership.xml · nonDerivative · entry 1 Ferrari Richard · CIK 0001034413 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 291,636 F1 · shares: These shares were purchased in connection with the Registrant's underwritten public offering of 12,500,000 shares of common stock. Titan Partners, a division of American Capital Partners, acted as the sole bookrunner for the offering, which priced on April 14, 2026, and closed on April 16, 2026. Read SEC document |
| April 16, 2026 Filed Apr 17, 2026 00:48 UTC | PurchaseCommon Stock | 31,250 | $0.80 | $25,000.00 |
DisclosureSEC source: 0001213900-26-044841 · ownership.xml · nonDerivative · entry 1 Cruickshank Tim · CIK 0002038418 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,230 F1 · shares: These shares were purchased in connection with the Registrant's underwritten public offering of 12,500,000 shares of common stock. Titan Partners, a division of American Capital Partners, acted as the sole bookrunner for the offering, which priced on April 14, 2026, and closed on April 16, 2026. F2 · balance_after: Includes 23,333 RSUs which have vested as per the Form 4 filed on October 3, 2025. Read SEC document |
|
| April 16, 2026 Filed Apr 17, 2026 00:46 UTC |
Ortigas-Wedekind MargaDirector
|
PurchaseCommon Stock | 25,000 | $0.80 | $20,000.00 |
DisclosureSEC source: 0001213900-26-044833 · ownership.xml · nonDerivative · entry 1 Ortigas-Wedekind Marga · CIK 0001453971 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 137,293 F1 · shares: These shares were purchased in connection with the Registrant's underwritten public offering of 12,500,000 shares of common stock. Titan Partners, a division of American Capital Partners, acted as the sole bookrunner for the offering, which priced on April 14, 2026, and closed on April 16, 2026. Read SEC document |
| April 16, 2026 Filed Apr 17, 2026 00:47 UTC |
Vajdic BranislavDirector
|
PurchaseCommon Stock | 31,250 | $0.80 | $25,000.00 |
DisclosureSEC source: 0001213900-26-044837 · ownership.xml · nonDerivative · entry 1 Vajdic Branislav · CIK 0001422425 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 909,914 F1 · shares: These shares were purchased in connection with the Registrant's underwritten public offering of 12,500,000 shares of common stock. Titan Partners, a division of American Capital Partners, acted as the sole bookrunner for the offering, which priced on April 14, 2026, and closed on April 16, 2026. Read SEC document |
| April 16, 2026 Filed Apr 17, 2026 00:48 UTC |
Elfrink WillemDirector
|
PurchaseCommon Stock | 187,500 | $0.80 | $150,000.00 |
DisclosureSEC source: 0001213900-26-044840 · ownership.xml · nonDerivative · entry 1 Elfrink Willem · CIK 0001893194 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 538,667 F1 · shares: These shares were purchased in connection with the Registrant's underwritten public offering of 12,500,000 shares of common stock. Titan Partners, a division of American Capital Partners, acted as the sole bookrunner for the offering, which priced on April 14, 2026, and closed on April 16, 2026. Read SEC document |
| April 16, 2026 Filed Apr 17, 2026 00:47 UTC |
JAFF MICHAEL RDirector
|
PurchaseCommon Stock | 31,250 | $0.80 | $25,000.00 |
DisclosureSEC source: 0001213900-26-044838 · ownership.xml · nonDerivative · entry 1 JAFF MICHAEL R · CIK 0001988352 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 31,250 F1 · shares: These shares were purchased in connection with the Registrant's underwritten public offering of 12,500,000 shares of common stock. Titan Partners, a division of American Capital Partners, acted as the sole bookrunner for the offering, which priced on April 14, 2026, and closed on April 16, 2026. F2 · ownership.direct: The shares are indirectly held by the Reporting Person under the entity Open Book Healthcare. F2 · ownership.nature: The shares are indirectly held by the Reporting Person under the entity Open Book Healthcare. Read SEC document |
| April 16, 2026 Filed Apr 17, 2026 00:47 UTC |
ENO Robert PaulPresident
|
PurchaseCommon Stock | 12,500 | $0.80 | $10,000.00 |
DisclosureSEC source: 0001213900-26-044834 · ownership.xml · nonDerivative · entry 1 ENO Robert Paul · CIK 0001963418 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,742 F1 · shares: These shares were purchased in connection with the Registrant's underwritten public offering of 12,500,000 shares of common stock. Titan Partners, a division of American Capital Partners, acted as the sole bookrunner for the offering, which priced on April 14, 2026, and closed on April 16, 2026. F2 · balance_after: Includes 23,333 RSUs which have vested as per the Form 4 filed on October 2, 2025. Read SEC document |
| April 16, 2026 Filed Apr 24, 2026 20:05 UTC Amendment |
Ferrari RichardDirector
|
PurchaseCommon Stock | 57,500 | $0.80 | $46,000.00 |
DisclosureSEC source: 0001213900-26-047514 · ownership.xml · nonDerivative · entry 1 Ferrari Richard · CIK 0001034413 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 286,636 F1 · shares: These shares were purchased in connection with the Registrant's underwritten public offering of 12,500,000 shares of common stock. Titan Partners, a division of American Capital Partners, acted as the sole bookrunner for the offering, which priced on April 14, 2026, and closed on April 16, 2026. This amendment restates the Reporting Person's original Form 4 filed on April 16, 2026, solely to correct an inadvertent error in the number of shares of common stock reported as acquired and the corresponding total beneficial ownership. The original filing reported the acquisition of 62,500 shares of common stock. The correct number of shares acquired was 57,500 shares of common stock. No other changes have been made to the original filing. Read SEC document |
| February 09, 2026 Filed Mar 23, 2026 21:38 UTC |
STROME MARK E10% owner
|
GrantCommon Stock (right to buy) · Derivative | 41,380 | $0.00 Strike: $1.43 | $0.00 |
DisclosureSEC source: 0001213900-26-033043 · ownership.xml · derivative · entry 1 STROME MARK E · CIK 0000919484 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,380 Underlying: Common Stock · 41,380 shares Expires 2036-01-01 F1 · derivative.exercise_date: Granted options on February 9, 2026 (the "Special Option"), one half of the total number of shares of common stock (the "Shares") subject to the Special Option shall vest on March 31, 2026, the three-month anniversary of the vesting commencement date beginning January 1, 2026, and the remaining Shares of common stock shall vest on June 30, 2026, the six-month anniversary of the vesting commencement date. These options have been issued from the Company's 2022 Equity Incentive Plan. Read SEC document |
| February 09, 2026 Filed Mar 23, 2026 21:38 UTC |
Ferrari RichardDirector
|
GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-26-033045 · ownership.xml · nonDerivative · entry 1 Ferrari Richard · CIK 0001034413 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 229,136 F1 · ownership.direct: These securities are restricted stock units (RSUs). Granted on February 9, 2026 (the "Special RSU"), one half of the total number of shares of common stock ("Shares") subject to the Special RSU shall vest on March 31, 2026, the three-month anniversary of the vesting commencement date beginning on January 1, 2026, and the remaining Shares subject to the Special RSU shall vest on June 30, 2026, the six-month anniversary of the vesting commencement date. These RSUs have been issued from the Company's 2022 Equity Incentive Plan. Read SEC document |
| February 09, 2026 Filed Mar 23, 2026 21:35 UTC | GrantCommon Stock (right to buy) · Derivative | 53,104 | $0.00 Strike: $1.45 | $0.00 |
DisclosureSEC source: 0001213900-26-033034 · ownership.xml · derivative · entry 1 Cruickshank Tim · CIK 0002038418 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,104 Underlying: Common Stock · 53,104 shares Expires 2036-01-01 F1 · derivative.exercise_date: Granted options on February 9, 2026 (the "Special Option"), one half of the total number of shares of common stock (the "Shares") subject to the Special Option shall vest on March 31, 2026, the three-month anniversary of the vesting commencement date beginning January 1, 2026, and the remaining Shares of common stock shall vest on June 30, 2026, the six-month anniversary of the vesting commencement date. These options have been issued from the Company's 2022 Equity Incentive Plan. Read SEC document |
|
| February 09, 2026 Filed Mar 23, 2026 21:39 UTC |
Ortigas-Wedekind MargaDirector
|
GrantCommon Stock(right to buy) · Derivative | 44,827 | $0.00 Strike: $1.43 | $0.00 |
DisclosureSEC source: 0001213900-26-033048 · ownership.xml · derivative · entry 1 Ortigas-Wedekind Marga · CIK 0001453971 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,827 Underlying: Common Stock · 44,827 shares Expires 2036-01-01 F1 · derivative.exercise_date: Granted options on February 9, 2026 (the "Special Option"), one half of the total number of shares of common stock (the "Shares") subject to the Special Option shall vest on March 31, 2026, the three-month anniversary of the vesting commencement date beginning January 1, 2026, and the remaining Shares of common stock shall vest on June 30, 2026, the six-month anniversary of the vesting commencement date. These options have been issued from the Company's 2022 Equity Incentive Plan. Read SEC document |
| February 09, 2026 Filed Mar 23, 2026 21:36 UTC |
Vajdic BranislavDirector · President
|
GrantCommon Stock (right to buy) · Derivative | 61,932 | $0.00 Strike: $1.45 | $0.00 |
DisclosureSEC source: 0001213900-26-033038 · ownership.xml · derivative · entry 1 Vajdic Branislav · CIK 0001422425 · Director · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,932 Underlying: Common Stock · 61,932 shares Expires 2036-01-01 F1 · derivative.exercise_date: Granted options on February 9, 2026 (the "Special Option"), one half of the total number of shares of common stock (the "Shares") subject to the Special Option shall vest on March 31, 2026, the three-month anniversary of the vesting commencement date beginning January 1, 2026, and the remaining Shares of common stock shall vest on June 30, 2026, the six-month anniversary of the vesting commencement date. These options have been issued from the Company's 2022 Equity Incentive Plan. Read SEC document |
| February 09, 2026 Filed Mar 23, 2026 17:31 UTC |
de Urioste GeorgeDirector
|
GrantCommon Stock (right to buy) · Derivative | 51,724 | $0.00 Strike: $1.43 | $0.00 |
DisclosureSEC source: 0001213900-26-033025 · ownership.xml · derivative · entry 1 de Urioste George · CIK 0001270068 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,724 Underlying: Common Stock · 51,724 shares Expires 2036-01-01 F1 · derivative.exercise_date: Granted options on February 9, 2026 (the "Special Option"), one half of the total number of shares of common stock (the "Shares") subject to the Special Option shall vest on March 31, 2026, the three-month anniversary of the vesting commencement date beginning January 1, 2026, and the remaining Shares of common stock shall vest on June 30, 2026, the six-month anniversary of the vesting commencement date. These options have been issued from the Company's 2022 Equity Incentive Plan. Read SEC document |
| February 09, 2026 Filed Mar 23, 2026 21:37 UTC |
JAFF MICHAEL RDirector
|
GrantCommon Stock | 20,689 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-26-033041 · ownership.xml · nonDerivative · entry 1 JAFF MICHAEL R · CIK 0001988352 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 95,809 F1 · ownership.direct: These securities are restricted stock units (RSUs). Granted on February 9, 2026 (the "Special RSU"), one half of the total number of shares of common stock ("Shares") subject to the Special RSU shall vest on March 31, 2026, the three-month anniversary of the vesting commencement date beginning on January 1, 2026, and the remaining Shares subject to the Special RSU shall vest on June 30, 2026, the six-month anniversary of the vesting commencement date. These RSUs have been issued from the Company's 2022 Equity Incentive Plan. Read SEC document |
| February 09, 2026 Filed Mar 23, 2026 21:34 UTC |
Elfrink WillemDirector
|
GrantCommon Stock (right to buy) · Derivative | 51,724 | $0.00 Strike: $1.43 | $0.00 |
DisclosureSEC source: 0001213900-26-033031 · ownership.xml · derivative · entry 1 Elfrink Willem · CIK 0001893194 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,724 Underlying: Common Stock · 51,724 shares Expires 2036-01-01 F1 · derivative.exercise_date: Granted options on February 9, 2026 (the "Special Option"), one half of the total number of shares of common stock (the "Shares") subject to the Special Option shall vest on March 31, 2026, the three-month anniversary of the vesting commencement date beginning January 1, 2026, and the remaining Shares of common stock shall vest on June 30, 2026, the six-month anniversary of the vesting commencement date. These options have been issued from the Company's 2022 Equity Incentive Plan. Read SEC document |
| February 09, 2026 Filed Mar 23, 2026 21:33 UTC |
Nelson Kenneth Warwick IIIDirector
|
GrantCommon Stock | 17,241 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-26-033029 · ownership.xml · nonDerivative · entry 1 Nelson Kenneth Warwick III · CIK 0001981293 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 144,388 F1 · ownership.direct: These securities are restricted stock units (RSUs). Granted on February 9, 2026 (the "Special RSU"), one half of the total number of shares of common stock ("Shares") subject to the Special RSU shall vest on March 31, 2026, the three-month anniversary of the vesting commencement date beginning on January 1, 2026, and the remaining Shares subject to the Special RSU shall vest on June 30, 2026, the six-month anniversary of the vesting commencement date. These RSUs have been issued from the Company's 2022 Equity Incentive Plan. Read SEC document |
| February 09, 2026 Filed Mar 23, 2026 21:29 UTC |
ENO Robert PaulPresident
|
GrantCommon Stock (right to buy) · Derivative | 55,172 | $0.00 Strike: $1.45 | $0.00 |
DisclosureSEC source: 0001213900-26-033021 · ownership.xml · derivative · entry 1 ENO Robert Paul · CIK 0001963418 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,172 Underlying: Common Stock · 55,172 shares Expires 2036-01-01 F1 · derivative.exercise_date: Granted options on February 9, 2026 (the "Special Option"), one half of the total number of shares of common stock (the "Shares") subject to the Special Option shall vest on March 31, 2026, the three-month anniversary of the vesting commencement date beginning January 1, 2026, and the remaining Shares of common stock shall vest on June 30, 2026, the six-month anniversary of the vesting commencement date. These options have been issued from the Company's 2022 Equity Incentive Plan. Read SEC document |
| December 18, 2025 Filed Dec 19, 2025 17:10 UTC |
de Urioste GeorgeDirector
|
SaleCommon Stock | 33,185 | $2.83 | $93,913.55 |
DisclosureSEC source: 0001213900-25-123939 · ownership.xml · nonDerivative · entry 2 de Urioste George · CIK 0001270068 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · price: The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4. Read SEC document |
| December 17, 2025 Filed Dec 19, 2025 17:10 UTC |
de Urioste GeorgeDirector
|
SaleCommon Stock | 23,961 | $3.68 | $88,176.48 |
DisclosureSEC source: 0001213900-25-123939 · ownership.xml · nonDerivative · entry 1 de Urioste George · CIK 0001270068 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,185 F1 · price: The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4. F2 · ownership.direct: These shares were sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) which vested in favor of the Reporting Person on the date of the Issuer's 2024 annual meeting of stockholders, which was held on June 12, 2024. Read SEC document |
| December 17, 2025 Filed Dec 22, 2025 22:44 UTC |
STROME MARK E10% owner
|
SaleCommon Stock | 250,000 | $3.58 | $895,000.00 |
DisclosureSEC source: 0001213900-25-124693 · ownership.xml · nonDerivative · entry 1 STROME MARK E · CIK 0000919484 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 2,900,000 F1 · balance_after: The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4. F2 · ownership.nature: The reported securities are held directly by Mark E. Strome Living Trust and Strome Dynasty, LLC. Mr. Strome has the authority to vote and dispose of the reported securities held by each of these entities. Mr. Strome disclaims beneficial ownership of the reported securities, except to the extent of his pecuniary interest therein. This report shall not be deemed an admission that Mr. Strome is a beneficial owner of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Read SEC document |
| April 07, 2025 Filed May 1, 2025 15:06 UTC |
Cruickshank TimChief Financial Officer
|
GrantCommon Stock (right to buy) · Derivative | 150,000 | $0.00 Strike: $1.65 | $0.00 |
DisclosureSEC source: 0001213900-25-038175 · ownership.xml · derivative · entry 1 Cruickshank Tim · CIK 0002038418 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 550,000 Underlying: Common Stock · 150,000 shares Expires 2035-04-07 F1 · derivative.exercise_date: Granted 150,000 options on April 7, 2025, which are scheduled to vest over 4 years with 25% vesting on April 7, 2025, and the remainder vesting and exercisable monthly thereafter. These options have been issued from the Company's 2022 Equity Incentive Plan. Read SEC document |
| April 07, 2025 Filed May 1, 2025 15:03 UTC |
Persen Kenneth HarryChief Technology Officer
|
GrantStock option (right to buy) · Derivative | 20,000 | $0.00 Strike: $1.65 | $0.00 |
DisclosureSEC source: 0001213900-25-038171 · ownership.xml · derivative · entry 1 Persen Kenneth Harry · CIK 0001942350 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 441,000 Underlying: Common Stock · 20,000 shares Expires 2035-04-07 F1 · derivative.exercise_date: Granted 20,000 options on April 7, 2025, which are scheduled to vest over 4 years with 25% vesting on April 07, 2025, and the remainder vesting and exercisable monthly thereafter. These options have been issued from the Company's 2022 Equity Incentive Plan. Read SEC document |
| April 07, 2025 Filed May 1, 2025 15:03 UTC |
Vajdic BranislavDirector · President
|
GrantStock option (right to buy) · Derivative | 180,000 | $0.00 Strike: $1.65 | $0.00 |
DisclosureSEC source: 0001213900-25-038170 · ownership.xml · derivative · entry 1 Vajdic Branislav · CIK 0001422425 · Director · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,374,000 Underlying: Common Stock · 180,000 shares Expires 2035-04-07 F1 · derivative.exercise_date: Granted 180,000 options on April 7, 2025, which are scheduled to vest over 4 years with 25% vesting on April 7, 2025, and the remainder vesting and exercisable monthly thereafter. These options have been issued from the Company's 2022 Equity Incentive Plan. Read SEC document |
| April 07, 2025 Filed May 1, 2025 15:05 UTC |
ENO Robert PaulChief Executive Officer
|
GrantStock option (right to buy) · Derivative | 320,000 | $0.00 Strike: $1.65 | $0.00 |
DisclosureSEC source: 0001213900-25-038173 · ownership.xml · derivative · entry 1 ENO Robert Paul · CIK 0001963418 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 856,000 Underlying: Common Stock · 320,000 shares Expires 2035-04-07 F1 · derivative.exercise_date: Granted 320,000 options on April 7, 2025, which are scheduled to vest over 4 years with 25% vesting on April 7, 2025, and the remainder vesting and exercisable monthly thereafter. These options have been issued from the Company's 2022 Equity Incentive Plan. Read SEC document |
| February 14, 2025 Filed Feb 22, 2025 01:00 UTC |
Ferrari RichardDirector
|
PurchaseCommon Stock | 29,412 | $1.70 | $50,000.40 |
DisclosureSEC source: 0001628280-25-007240 · wk-form4_1740186016.xml · nonDerivative · entry 1 Ferrari Richard · CIK 0001034413 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 179,136 F1 · shares: These shares were purchased in the Issuers offering which closed on February 14, 2025 Read SEC document |
| February 14, 2025 Filed Feb 22, 2025 00:55 UTC | PurchaseCommon Stock | 17,647 | $1.70 | $29,999.90 |
DisclosureSEC source: 0001628280-25-007239 · wk-form4_1740185708.xml · nonDerivative · entry 1 Cruickshank Tim · CIK 0002038418 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,647 F1 · shares: These shares were purchased in the Issuers offering which closed on February 14, 2025 Read SEC document |
|
| September 25, 2024 Filed Feb 22, 2025 00:55 UTC | GrantCommon Stock (right to buy) · Derivative | 400,000 | $2.28 Strike: $2.28 | $912,000.00 |
DisclosureSEC source: 0001628280-25-007239 · wk-form4_1740185708.xml · derivative · entry 2 Cruickshank Tim · CIK 0002038418 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 400,000 Underlying: Common Stock · 400,000 shares Expires 2034-09-25 F2 · derivative.exercise_date: Granted 400,000 options on September 25, 2024, which are scheduled to vest over 4 years with 25% vesting on September 26, 2025, and the remainder vesting and exercisable monthly thereafter. Read SEC document |
|
| September 06, 2024 Filed Sep 11, 2024 16:36 UTC |
de Urioste GeorgeDirector
|
SaleCommon Stock | 1,674 | $2.34 | $3,917.16 |
DisclosureSEC source: 0001628280-24-040139 · wk-form4_1726086999.xml · nonDerivative · entry 1 de Urioste George · CIK 0001270068 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,146 F1 · ownership.direct: These shares were sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) which vested in favor of the Reporting Person on the date of the Issuer's 2024 annual meeting of stockholders, which was held on June 12, 2024. Read SEC document |
| August 30, 2024 Filed Sep 4, 2024 18:25 UTC |
de Urioste GeorgeDirector
|
SaleCommon Stock | 5,500 | $2.31 | $12,705.00 |
DisclosureSEC source: 0001628280-24-039383 · wk-form4_1725485085.xml · nonDerivative · entry 1 de Urioste George · CIK 0001270068 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,820 F1 · ownership.direct: These shares were sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) which vested in favor of the Reporting Person on the date of the Issuer's 2024 annual meeting of stockholders, which was held on June 12, 2024. Read SEC document |
| August 27, 2024 Filed Aug 29, 2024 16:18 UTC |
de Urioste GeorgeDirector
|
SaleCommon Stock | 2,194 | $2.26 | $4,958.44 |
DisclosureSEC source: 0001628280-24-038817 · wk-form4_1724962716.xml · nonDerivative · entry 1 de Urioste George · CIK 0001270068 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,320 F1 · ownership.direct: These shares were sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) which vested in favor of the Reporting Person on the date of the Issuer's 2024 annual meeting of stockholders, which was held on June 12, 2024. Read SEC document |
| August 26, 2024 Filed Aug 27, 2024 15:07 UTC |
de Urioste GeorgeDirector
|
SaleCommon Stock | 300 | $2.38 | $714.00 |
DisclosureSEC source: 0001628280-24-038522 · wk-form4_1724785648.xml · nonDerivative · entry 2 de Urioste George · CIK 0001270068 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,514 F1 · ownership.direct: These shares were sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) which vested in favor of the Reporting Person on the date of the Issuer's 2024 annual meeting of stockholders, which was held on June 12, 2024. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.